HUTCHMED Sets 30 July Board Meeting to Approve 2026 Interim Results; Webcast Details Announced

Bulletin Express

06/30

HUTCHMED (China) Limited has scheduled its board meeting for 30 July 2026 to approve and publish interim results for the six months ended 30 June 2026. The announcement will be released at 7:00 p.m. Hong Kong Time on the same day.

Management will host two live webcasts to discuss the results: an English session with Q&A at 8:00 p.m. on 30 July 2026 and a Putonghua session at 8:30 a.m. on 31 July 2026. Both events can be accessed through the company’s website (www.hutch-med.com/event/), where presentation materials will be available for download shortly before the broadcasts, and replays will be posted afterward.

The board is chaired by Non-executive Director Dr Dan Eldar. Executive leadership includes Chief Executive Officer and Chief Scientific Officer Dr Weiguo Su and Acting Chief Executive Officer and Chief Financial Officer Johnny Cheng Chig Fung. The company secretary is Non-executive Director Edith Shih.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1186080921"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1186080921\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1186080921?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-30 16:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1186080921","market":"hk","top_or_hot":-1,"title":"HUTCHMED Sets 30 July Board Meeting to Approve 2026 Interim Results; Webcast Details Announced","media":"Bulletin Express","content":"<p>HUTCHMED (China) Limited has scheduled its board meeting for 30 July 2026 to approve and publish interim results for the six months ended 30 June 2026. The announcement will be released at 7:00 p.m. Hong Kong Time on the same day.</p>\n<p>Management will host two live webcasts to discuss the results: an English session with Q&A at 8:00 p.m. on 30 July 2026 and a Putonghua session at 8:30 a.m. on 31 July 2026. Both events can be accessed through the company’s website (www.hutch-med.com/event/), where presentation materials will be available for download shortly before the broadcasts, and replays will be posted afterward.</p>\n<p>The board is chaired by Non-executive Director Dr Dan Eldar. Executive leadership includes Chief Executive Officer and Chief Scientific Officer Dr Weiguo Su and Acting Chief Executive Officer and Chief Financial Officer Johnny Cheng Chig Fung. The company secretary is Non-executive Director Edith Shih.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HUTCHMED Sets 30 July Board Meeting to Approve 2026 Interim Results; Webcast Details Announced</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHUTCHMED Sets 30 July Board Meeting to Approve 2026 Interim Results; Webcast Details Announced\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-06-30 16:44</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>HUTCHMED (China) Limited has scheduled its board meeting for 30 July 2026 to approve and publish interim results for the six months ended 30 June 2026. The announcement will be released at 7:00 p.m. Hong Kong Time on the same day.</p>\n<p>Management will host two live webcasts to discuss the results: an English session with Q&A at 8:00 p.m. on 30 July 2026 and a Putonghua session at 8:30 a.m. on 31 July 2026. Both events can be accessed through the company’s website (www.hutch-med.com/event/), where presentation materials will be available for download shortly before the broadcasts, and replays will be posted afterward.</p>\n<p>The board is chaired by Non-executive Director Dr Dan Eldar. Executive leadership includes Chief Executive Officer and Chief Scientific Officer Dr Weiguo Su and Acting Chief Executive Officer and Chief Financial Officer Johnny Cheng Chig Fung. The company secretary is Non-executive Director Edith Shih.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00013","symbol_name":"和黃醫藥","start_time":0,"source_url":"","article_id":"1186080921","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1186080921","pubTimestamp":1782809054,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"HUTCHMED (China) Limited has scheduled its board meeting for 30 July 2026 to approve and publish interim results for the six months ended 30 June 2026. The announcement will be released at 7:00 p.m....","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00013":"和黄医药"},"translate_title":"和黄医药定于7月30日召开董事会批准2026年中期业绩；网络直播详情公布","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00013":1},"content_text":"HUTCHMED (China) Limited has scheduled its board meeting for 30 July 2026 to approve and publish interim results for the six months ended 30 June 2026. The announcement will be released at 7:00 p.m. Hong Kong Time on the same day.\nManagement will host two live webcasts to discuss the results: an English session with Q&A at 8:00 p.m. on 30 July 2026 and a Putonghua session at 8:30 a.m. on 31 July 2026. Both events can be accessed through the company’s website (www.hutch-med.com/event/), where presentation materials will be available for download shortly before the broadcasts, and replays will be posted afterward.\nThe board is chaired by Non-executive Director Dr Dan Eldar. Executive leadership includes Chief Executive Officer and Chief Scientific Officer Dr Weiguo Su and Acting Chief Executive Officer and Chief Financial Officer Johnny Cheng Chig Fung. The company secretary is Non-executive Director Edith Shih.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"conferences,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}